Adicet Bio (ACET) Short-term Investments (2018 - 2026)

Adicet Bio's Short-term Investments history runs 7 years deep, the most recent figure standing at $101.3 million for Q1 2026.

• In Q1 2026, Short-term Investments fell 17.14% year-over-year to $101.3 million; the TTM figure through Mar 2026 stood at $101.3 million (down 17.14% YoY), while the FY2025 annual figure was $119.6 million, changed 0.16% from the prior year.
• Short-term Investments for Q1 2026 stood at $101.3 million, down from $119.6 million in the prior quarter.
• The five-year high for Short-term Investments was $122.3 million in Q1 2025, with the low at $74.0 million in Q3 2025.
• The 3-year median for Short-term Investments is $101.3 million (2026), against an average of $103.4 million.
• Peak annual rise in Short-term Investments reached 0.16% in 2025, while the deepest fall reached 23.38% in 2025.
• Adicet Bio's Short-term Investments stood at $119.8 million in 2024, then retreated by 0.16% to $119.6 million in 2025, then fell by 15.27% to $101.3 million in 2026.
• Business Quant data shows ACET's Short-term Investments at $101.3 million in Q1 2026, $119.6 million in Q4 2025, and $74.0 million in Q3 2025.